These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7946804)

  • 21. [The anti-ischemic effects of ACE inhibitors after an acute myocardial infarct].
    Rutherford JD
    Rev Clin Esp; 1996 Dec; 196(4 Monografico):41-2. PubMed ID: 9139332
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of myocardial ischemia with reference to blood pressure values].
    Schneeweiss A; Wiegand V
    Cardiology; 1993; 82 Suppl 2():58-65. PubMed ID: 8100187
    [No Abstract]   [Full Text] [Related]  

  • 23. [Acute changes of coronary and global hemodynamics in patients with angina pectoris and arterial hypertension caused by celiprolol and metoprolol].
    Franz N; Modersohn D; Linss G; Heublein B; Gola G; Bruch L; Walde T
    Radiol Diagn (Berl); 1990; 31(6):625-8. PubMed ID: 1982742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [ACE-inhibitors in angina pectoris].
    Kjøller-Hansen L; Steffensen R; Grande P
    Ugeskr Laeger; 1998 Mar; 160(10):1494-8. PubMed ID: 9520622
    [No Abstract]   [Full Text] [Related]  

  • 25. ["Using chance, despite high NNT"].
    Zeiher A
    MMW Fortschr Med; 2003 Sep; 145(38):12. PubMed ID: 14603674
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hemodynamic effects of captopril, an ACE inhibitor, in patients after aortocoronary bypass].
    Ivancan V; Husedzinović I; Nikić N; Baudoin Z
    Lijec Vjesn; 1995 Jun; 117 Suppl 2():103-4. PubMed ID: 8649134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [What is safe in the therapy of hypertensive heart disease?].
    Motz W; Strauer BE
    Internist (Berl); 1985 Dec; 26(12):750-64. PubMed ID: 2867983
    [No Abstract]   [Full Text] [Related]  

  • 28. [Current aspects of ACE inhibitor therapy from the cardiologic viewpoint].
    Klein W; Eber B; Gasser R; Stoschitzky K; Schumacher M; Fruhwald FM; Zweiker R
    Wien Med Wochenschr; 1996; 146(11):221-4. PubMed ID: 8928518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of inhibitors of the angiotensin-converting enzyme on endothelial dysfunction in patients with stable angina pectoris].
    Volkov VI; Abidova KR
    Lik Sprava; 2001; (3):62-5. PubMed ID: 11560030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The angiotensin-converting enzyme inhibitor in the treatment of angina pectoris].
    Bussmann WD; Wittig RA; Brunner I; Bahrmann H
    Dtsch Med Wochenschr; 1992 Apr; 117(16):603-6. PubMed ID: 1568426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ergometric evaluation of the effects of captopril in hypertensive patients with stable angina.
    Strozzi C; Cocco G; Portaluppi F; Padula A; Urso L; Alfiero R; Rizzo A; Tasini MT
    J Hypertens Suppl; 1985 Nov; 3(2):S147-8. PubMed ID: 3910772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myocardial uptake and biochemical and hemodynamic effects of ACE inhibitors in humans.
    Zeitz CJ; Campbell DJ; Horowitz JD
    Hypertension; 2003 Mar; 41(3):482-7. PubMed ID: 12623947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of antiarrhythmic activity of captopril and enalaprilat in experimental cardiac arrhythmias in rabbits. Part I.
    Dzielska-Olczak M; Polakowski P; Kubik-Bogucka E
    Pol J Pharmacol; 1998; 50(3):225-31. PubMed ID: 9861630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Modification of hemodynamics by angiotensin converting enzyme inhibitors in heart failure].
    Ertl G; Gaudron P; Eilles C
    Herz; 1990 Jun; 15(3):158-63. PubMed ID: 2198216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficiancy Angiotensin -converting enzyme inhibitors for the clinical practice].
    Abuladze GV; Nebieridze MI; Narsiia EV; Erkomaishvili IG; Pipiia NG
    Georgian Med News; 2011 Jun; (195):37-40. PubMed ID: 21778538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of chronic stable angina pectoris with angiotensin converting enzyme inhibition--a randomized, placebo-controlled, double-blind cross-over study].
    Odenthal HJ; Thürmann P; Wiechmann HW; Josephs W; Lenga P
    Z Kardiol; 1991 Jun; 80(6):392-6. PubMed ID: 1926985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin converting enzyme inhibitors in angina and myocardial infarction. What role will they play in the 1990s?
    Ertl G
    Drugs; 1993 Aug; 46(2):209-18. PubMed ID: 7691512
    [No Abstract]   [Full Text] [Related]  

  • 39. [The anti-ischemic effect of angiotensin-converting enzyme inhibitors in treating stable stenocardia of effort in middle-aged and elderly patients].
    Lazebnik LB; Vertkin AL; Drozdova SL; Konev IuV; Goncharov LF
    Ter Arkh; 1996; 68(4):40-2. PubMed ID: 9324787
    [No Abstract]   [Full Text] [Related]  

  • 40. Anti-ischemic effects of cilazapril in patients with both hypertension and angina pectoris. Preliminary report of a pilot study.
    Schneeweiss A; Marmor AT; Rettig-Stürmer G
    Cardiology; 1991; 79(1):46-8. PubMed ID: 1838032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.